The ABCs On CEFs | Seeking Alpha
Oct 10, 2024 · Closed-end funds offer unique advantages like fixed share numbers and access to diverse assets. Learn more on CEFs and their benefits for portfolio diversification.
Comstock: Updates And New Developments (NYSE:LODE)
Oct 10, 2024 · Comstock's strategic transactions inject $325m with cash flow from solar panel recycling operations and new fuel licenses in three refineries. Learn more on LODE stock here.
SoundHound (SOUN) Stock: Acquisition Makes Me Jittery
SoundHound AI's stock has surged over 100% YTD, driven by a raised revenue outlook and strategic acquisitions. Check out why I assign SOUN a neutral rating.
My Top 15 High Growth Dividend Stocks For October 2024
Quality Stocks. The SPDR S&P 500 ETF Trust added 2.10% in September pushing it above 20% year-to-date.If the Fund can maintain this return in Q4 it would deliver back-to-back 20% plus returns in ...
Progressive Stock: A Backbone For Your Portfolio (NYSE:PGR)
Sep 25, 2024 · Progressive is a top performer in insurance, with impressive returns, strong financials, and growth potential, making it a solid investment choice. See more here.
What to expect from Tesla's robotaxi event - Seeking Alpha
All Stocks; Top Rated Stocks; Top Growth Stocks; Top Value Stocks; Top Small Cap Stocks; Stocks by Quant; Most Shorted Stocks; Strong Buy Stocks - Short Squeeze
Tesla Stock Is A Great Buy Before The October Event - Seeking Alpha
Sep 30, 2024 · Summary. Tesla, Inc.'s share price is poised for a trend reversal, driven by optimism surrounding upcoming events like the October Robotaxi announcement and long-term growth prospects.
Inside Dell's Explosive AI Expansion - Seeking Alpha
Dell's strategy to target a $174 billion AI market by 2027, with ISG leading the way with innovative products and collaborations. Explore more details here.
Applied Therapeutics: Pushing Towards FDA Approval - Seeking …
Sep 4, 2024 · Summary. Today, we revisit clinical stage developmental concern Applied Therapeutics, Inc. for the first time in 2024. The company is moving towards its first FDA approval before yearend, and ...
Bristol-Myers Squibb: Cobenfy Approval A Major Coup For …
Sep 27, 2024 · Bristol-Myers Squibb's acquisition of Karuna and FDA approval of Cobenfy signal growth potential, with focus on driving revenue. Read my update on BMY stock.